<DOC>
	<DOCNO>NCT01131559</DOCNO>
	<brief_summary>The specific aim study evaluate efficacy tolerability lisdexamfetamine adjunctive treatment bipolar disorder .</brief_summary>
	<brief_title>Adjunctive Lisdexamfetamine ( LDX ) Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Subjects meet DSMIVTR criterion bipolar I II disorder , Women pregnant , lactating , childbearing potential use adequate contraceptive measure . Clinically unstable medical disease , include cardiovascular , hepatic , renal , gastrointestinal , pulmonary , metabolic , endocrine systemic disease . Subjects biochemically euthyroid enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>manic depression</keyword>
	<keyword>depression</keyword>
	<keyword>Bipolar I II</keyword>
</DOC>